IRLAB: Invitation to the Year-End Report 2025 Presentation and Webcast
IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A)(STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will hold a presentation in conjunction with the publication of the year-end report for 2025. The interim report will be published on Wednesday, February 25, 2026, at 07:00 CET. The presentation will be held on February 25, 2026, at 10:00 CET via digital webcast....
Read more









